我要投票 茵花在女性洗液行业中的票数:5
· 外 推 电 报 ·
2024-11-21 19:09:35 星期四

【茵花是哪个国家的品牌?】

茵花是什么牌子?「茵花」是 重庆希尔安药业有限公司 旗下著名品牌。该品牌发源于重庆市,由创始人唐董在1994年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

重庆希尔安药业有限公司,茵花洗液,女性洗液知名品牌,重庆市著名商标,集研发、生产、销售中药材种植/中药饮片加工为一体高新技术企业


希尔安药业起源于公元1698年的“伍舒芳草堂”,承袭“重庆中药总厂”之制药精髓,至今已有300多年的历史。公司始终秉持“德布天下,药济苍生”的企业理念,树百年商誉”为企业目标,如今已经发展成一家集研发、生产、销售于一体的综合性制药企业。

希尔安药业位于重庆市合川工业园区,总资产12.5亿元,占地面积330亩,Ⅰ期工程总建筑面积为76207m2,总投资达6亿元;颗粒剂、胶囊剂、片剂等15个剂型通过2010年版GMP认证,年产值将达到50亿元。新生产基地实现厂房标准化、生产过程自动化、环境保护科学化。

公司产品资源丰富,拥有生产批文166个,其中71个品种列入《国家基本医疗保险药品目录》;22个品种列入《国家基本药物目录》;12个中药保护品种,2个优质优价品种。

公司旗下两大商业机构:希尔安药品销售公司;希尔安康泽医药连锁有限公司;四大营销机构:处方药营销中心、OTC营销中心、普药营销中心、新医疗营销中心;实施“广覆盖、深耕作”营销战略,销售网络覆盖全国31个省、自治区、直辖市以及东南亚、欧洲、美洲等部分海外市场,形成从省会城市综合医院到区县以及乡镇卫生院、个体诊所、零售药房深度耕作的销售格局,致力于打造骨科、儿科、肿瘤科、皮肤科等多条具有竞争优势的产品线,实现每年销售额增长50%以上的目标。

公司下属两家研发机构:重庆思科药物研究所有限公司,专注于化药、中药及天然药物、大健康产品的开发;重庆科润生物医药研发有限公司,专注于生物制剂研发;拥有重庆市博士后科研工作站、重庆市企业技术中心、重庆市中药制剂工艺工程技术研究中心等多个市级技术创新平台。公司始终以“科技”为手段,坚持“仿创结合、药物与大健康产品研发并重”的方针,形成“筛选一批、研发一批、储备一批”的研发格局。

为了适应国家不断推进的医疗卫生体制改革以及新的经济形势,公司大力实施人才战略、品牌战略、创新战略;传承三百年伍舒芳中药文化精髓,构建以“德布天下,药济苍生”为核心的企业文化体系;打造市场准入和市场营销两大核心竞争力,实现颠覆式发展,力争在未来6~8年内,将希尔安打造成百亿级医药企业。


英文翻译:Chongqing hilan Pharmaceutical Co., Ltd., a famous brand of Yinhua lotion, women's lotion and Chongqing famous trademark, is a high-tech enterprise integrating R & D, production and sales of Chinese herbal medicine planting / processing of Chinese herbal pieces. Hilan pharmaceutical industry originated from wushufang thatched cottage in 1698 A.D., inherits the pharmaceutical essence of Chongqing general herbal medicine factory, and has a history of more than 300 years. The company always adheres to the enterprise concept of "debuxia, medicine for the people" and the enterprise goal of "building a hundred years' goodwill". Now it has developed into a comprehensive pharmaceutical enterprise integrating research and development, production and sales. Hilan pharmaceutical is located in Hechuan Industrial Park, Chongqing, with a total asset of 1.25 billion yuan, covering an area of 330 mu. The total construction area of phase I project is 76207m2, with a total investment of 600 million yuan. 15 dosage forms such as granules, capsules and tablets have passed GMP certification in 2010, with an annual output value of 5 billion yuan. The new production base realizes factory standardization, production process automation and environmental protection scientization. The company has rich product resources, with 166 production approvals, 71 of which are listed in the national basic medical insurance drug catalog; 22 of which are listed in the national basic drug catalog; 12 of which are protected by traditional Chinese medicine, and 2 of which are of high quality and high price. The company's two major commercial organizations: hilan pharmaceutical sales company; hilan Kangze pharmaceutical chain Co., Ltd.; four major marketing organizations: prescription drug marketing center, OTC marketing center, general drug marketing center, new medical marketing center; the implementation of the "wide coverage, deep cultivation" marketing strategy, the sales network covers 31 provinces, autonomous regions, municipalities directly under the central government, as well as Southeast Asia, Europe, the United States Some overseas markets, such as Zhouzhou, have formed a sales pattern of deep cultivation from provincial capital city general hospitals to district and county health centers, individual clinics and retail pharmacies. They are committed to building multiple product lines with competitive advantages, such as orthopedics, pediatrics, oncology and dermatology, to achieve the goal of increasing sales by more than 50% every year. Two R & D institutions under the company: Chongqing Cisco Pharmaceutical Research Institute Co., Ltd., which focuses on the development of chemical medicine, traditional Chinese medicine, natural medicine and large health products; Chongqing Kerun biomedical research and Development Co., Ltd., which focuses on the research and development of biological agents; Chongqing postdoctoral research station, Chongqing enterprise technology center, Chongqing Traditional Chinese medicine preparation process engineering technology research center, etc Municipal technology innovation platforms. The company always takes "science and technology" as a means, adheres to the policy of "combination of imitation and innovation, equal emphasis on research and development of drugs and large health products", and forms a research and development pattern of "selecting a batch, researching and developing a batch, and reserving a batch". In order to adapt to the constantly advancing medical and health system reform and the new economic situation, the company vigorously implements the talent strategy, brand strategy and innovation strategy; inherits the essence of Wu Shufang's traditional Chinese medicine culture for three hundred years, constructs the enterprise culture system with the core of "debriefing the world, medicine saving the people"; creates the two core competitiveness of market access and marketing, and realizes the subversive development, Strive to build hilan into a 10 billion level pharmaceutical enterprise in the next 6-8 years.

本文链接: https://www.waitui.com/brand/7094bf05f.html 联系电话:023-67893722,67893723

千城特选小程序码

7×24h 快讯

国资委:目前最紧迫的是要向前瞻性战略性新兴产业集中

36氪获悉,据国务院国资委官网,11月19日至20日,国务院国资委党委举办理论学习中心组集体学习会暨厅局级干部研修班。大家一致认为,要完善国有经济布局优化和结构调整机制,推动中央企业加快构建现代化产业体系。要谋划好国资央企“十五五”规划,把行业研究透、家底理清楚,科学严谨、能够落地。要更加有效推进国有资本“三个集中”,目前最紧迫的是要向前瞻性战略性新兴产业集中,在维护国家国防安全、粮食安全、能源安全等方面发挥战略安全兜底作用,深入推进战略性、专业化重组。

2小时前

人民银行科技司:正在加紧出台金融业数据跨境流动合规指南

在11月21日2024年世界互联网大会乌镇峰会“数据治理论坛”上,中国人民银行科技司司长李伟介绍,年初,在国家网信部门统筹指导下,人民银行会同其他金融管理部门开展研究,编制了《促进和规范金融业数据跨境流动合规指南》。目前,《指南》正在加紧出台中。《指南》明确,不含金融重要数据或个人信息的数据,在履行法律规定等一般性合规义务,以及满足国家网信部门、金融管理部门有关规定的前提下,可以自由跨境流动,自主向境外提供。(中证报)

2小时前

搜狗输入法打造全新AI搜索体验,输入即搜索

36氪获悉,11月21日,腾讯搜狗输入法进行全新升级,在腾讯混元大模型技术的支持下,推出和升级AI搜索、AI快查等重要功能,实现“输入即搜索”,在学习、办公、社交等场景中,做到边聊边搜、边写边搜,智能化提供参考信息。更重要的是,用户将可免费使用全部AI服务。

2小时前

阿里巴巴整合国内和海外电商,成立电商事业群,由蒋凡担任CEO

36氪独家获悉,11月21日,阿里巴巴集团CEO吴泳铭发布内部邮件,宣布整合国内和海外电商,成立电商事业群,由蒋凡担任CEO,向吴泳铭汇报。据了解,新的电商事业群将全面整合淘宝天猫集团、国际数字商业集团以及1688、闲鱼等电商业务,形成覆盖国内外全产业链的业务集群。信中表示,“通过整合集团内的所有电商资源,激发多年沉淀的能力,服务好国内和全球消费者,同时帮助更多中小企业同步拓展国内及海外市场。”

2小时前

快手-W获南向资金净买入7亿港元

南向资金今日净买入46.66亿元。港股通(沪)方面,快手-W、阿里巴巴-W分别获净买入7.0亿港元、1.4亿港元;小米集团-W净卖出额居首,金额为2.04亿港元;港股通(深)方面,阿里巴巴-W、小米集团-W分别获净买入2.83亿港元、1.84亿港元;融创中国净卖出额居首,金额为0.77亿港元。(第一财经)

2小时前

本页详细列出关于Femfresh芳芯的品牌信息,含品牌所属公司介绍,Femfresh芳芯所处行业的品牌地位及优势。
咨询